Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 10 |
GO:0043226 | organelle | 2 | 10 |
GO:0043227 | membrane-bounded organelle | 3 | 10 |
GO:0043229 | intracellular organelle | 3 | 10 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0000808 | origin recognition complex | 2 | 1 |
GO:0005664 | nuclear origin of replication recognition complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AZG4
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006259 | DNA metabolic process | 4 | 11 |
GO:0006260 | DNA replication | 5 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0051301 | cell division | 2 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:0000075 | cell cycle checkpoint signaling | 4 | 1 |
GO:0000076 | DNA replication checkpoint signaling | 6 | 1 |
GO:0006270 | DNA replication initiation | 5 | 1 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 4 | 1 |
GO:0007165 | signal transduction | 2 | 1 |
GO:0007346 | regulation of mitotic cell cycle | 5 | 1 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 7 | 1 |
GO:0010564 | regulation of cell cycle process | 5 | 1 |
GO:0010948 | negative regulation of cell cycle process | 6 | 1 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 8 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 1 |
GO:0033314 | mitotic DNA replication checkpoint signaling | 6 | 1 |
GO:0035556 | intracellular signal transduction | 3 | 1 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 5 | 1 |
GO:0044818 | mitotic G2/M transition checkpoint | 5 | 1 |
GO:0045786 | negative regulation of cell cycle | 5 | 1 |
GO:0045930 | negative regulation of mitotic cell cycle | 6 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051726 | regulation of cell cycle | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 1 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 1 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6 | 1 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 7 | 1 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 7 | 1 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 8 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003677 | DNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0005488 | binding | 1 | 11 |
GO:0005524 | ATP binding | 5 | 11 |
GO:0016462 | pyrophosphatase activity | 5 | 8 |
GO:0016787 | hydrolase activity | 2 | 8 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 8 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 8 |
GO:0016887 | ATP hydrolysis activity | 7 | 8 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 8 |
GO:0030554 | adenyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003688 | DNA replication origin binding | 7 | 1 |
GO:0003690 | double-stranded DNA binding | 5 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 276 | 280 | PF00656 | 0.470 |
CLV_C14_Caspase3-7 | 392 | 396 | PF00656 | 0.532 |
CLV_MEL_PAP_1 | 219 | 225 | PF00089 | 0.352 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.151 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.340 |
CLV_NRD_NRD_1 | 326 | 328 | PF00675 | 0.437 |
CLV_NRD_NRD_1 | 349 | 351 | PF00675 | 0.489 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.566 |
CLV_PCSK_FUR_1 | 3 | 7 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.279 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.340 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 349 | 351 | PF00082 | 0.261 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.481 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 328 | 330 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.304 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.258 |
CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.357 |
CLV_PCSK_SKI1_1 | 251 | 255 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.390 |
CLV_Separin_Metazoa | 368 | 372 | PF03568 | 0.325 |
DEG_APCC_DBOX_1 | 333 | 341 | PF00400 | 0.363 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.567 |
DOC_CYCLIN_RxL_1 | 159 | 169 | PF00134 | 0.365 |
DOC_CYCLIN_yCln2_LP_2 | 404 | 410 | PF00134 | 0.472 |
DOC_MAPK_gen_1 | 194 | 201 | PF00069 | 0.258 |
DOC_MAPK_gen_1 | 82 | 91 | PF00069 | 0.270 |
DOC_MAPK_MEF2A_6 | 141 | 149 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 307 | 315 | PF00069 | 0.310 |
DOC_MAPK_MEF2A_6 | 371 | 380 | PF00069 | 0.328 |
DOC_MAPK_MEF2A_6 | 397 | 404 | PF00069 | 0.475 |
DOC_MAPK_RevD_3 | 313 | 329 | PF00069 | 0.454 |
DOC_PP1_RVXF_1 | 164 | 171 | PF00149 | 0.258 |
DOC_PP1_RVXF_1 | 296 | 303 | PF00149 | 0.366 |
DOC_PP1_RVXF_1 | 358 | 364 | PF00149 | 0.427 |
DOC_PP2B_LxvP_1 | 171 | 174 | PF13499 | 0.348 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.258 |
DOC_USP7_UBL2_3 | 155 | 159 | PF12436 | 0.267 |
DOC_USP7_UBL2_3 | 162 | 166 | PF12436 | 0.246 |
LIG_14-3-3_CanoR_1 | 252 | 261 | PF00244 | 0.307 |
LIG_14-3-3_CanoR_1 | 3 | 13 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 371 | 376 | PF00244 | 0.465 |
LIG_Actin_WH2_2 | 357 | 373 | PF00022 | 0.429 |
LIG_AP2alpha_1 | 295 | 299 | PF02296 | 0.425 |
LIG_BIR_III_4 | 419 | 423 | PF00653 | 0.429 |
LIG_eIF4E_1 | 175 | 181 | PF01652 | 0.338 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.364 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.313 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.515 |
LIG_FHA_1 | 312 | 318 | PF00498 | 0.350 |
LIG_FHA_1 | 320 | 326 | PF00498 | 0.424 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.430 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.213 |
LIG_FHA_2 | 281 | 287 | PF00498 | 0.401 |
LIG_Integrin_RGD_1 | 38 | 40 | PF01839 | 0.388 |
LIG_LIR_Gen_1 | 169 | 176 | PF02991 | 0.278 |
LIG_LIR_Gen_1 | 297 | 306 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 398 | 408 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.257 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.265 |
LIG_LIR_Nem_3 | 245 | 250 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 398 | 404 | PF02991 | 0.458 |
LIG_MAD2 | 166 | 174 | PF02301 | 0.258 |
LIG_PDZ_Class_2 | 426 | 431 | PF00595 | 0.445 |
LIG_Pex14_2 | 134 | 138 | PF04695 | 0.258 |
LIG_Pex14_2 | 295 | 299 | PF04695 | 0.425 |
LIG_Pex14_2 | 90 | 94 | PF04695 | 0.390 |
LIG_SH2_CRK | 408 | 412 | PF00017 | 0.454 |
LIG_SH2_GRB2like | 175 | 178 | PF00017 | 0.371 |
LIG_SH2_STAT3 | 210 | 213 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.302 |
LIG_SH3_3 | 351 | 357 | PF00018 | 0.518 |
LIG_SUMO_SIM_anti_2 | 314 | 319 | PF11976 | 0.285 |
LIG_SUMO_SIM_anti_2 | 365 | 371 | PF11976 | 0.333 |
LIG_SUMO_SIM_par_1 | 146 | 152 | PF11976 | 0.258 |
LIG_SUMO_SIM_par_1 | 179 | 184 | PF11976 | 0.258 |
LIG_SUMO_SIM_par_1 | 270 | 277 | PF11976 | 0.314 |
LIG_SUMO_SIM_par_1 | 279 | 286 | PF11976 | 0.341 |
LIG_SUMO_SIM_par_1 | 338 | 344 | PF11976 | 0.399 |
LIG_TRAF2_1 | 396 | 399 | PF00917 | 0.445 |
LIG_TRAF2_1 | 44 | 47 | PF00917 | 0.374 |
LIG_TRAF2_1 | 8 | 11 | PF00917 | 0.526 |
LIG_TRFH_1 | 403 | 407 | PF08558 | 0.310 |
LIG_UBA3_1 | 59 | 67 | PF00899 | 0.302 |
MOD_CK1_1 | 209 | 215 | PF00069 | 0.453 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.428 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.421 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.264 |
MOD_CK2_1 | 280 | 286 | PF00069 | 0.484 |
MOD_CK2_1 | 371 | 377 | PF00069 | 0.362 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.307 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.510 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.263 |
MOD_GSK3_1 | 205 | 212 | PF00069 | 0.456 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.453 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.469 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.310 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.416 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.274 |
MOD_N-GLC_1 | 352 | 357 | PF02516 | 0.272 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.675 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.366 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.403 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.301 |
MOD_NEK2_1 | 302 | 307 | PF00069 | 0.335 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.295 |
MOD_NEK2_1 | 341 | 346 | PF00069 | 0.344 |
MOD_NEK2_1 | 352 | 357 | PF00069 | 0.382 |
MOD_NEK2_1 | 421 | 426 | PF00069 | 0.489 |
MOD_NEK2_2 | 280 | 285 | PF00069 | 0.384 |
MOD_PIKK_1 | 209 | 215 | PF00454 | 0.453 |
MOD_PIKK_1 | 238 | 244 | PF00454 | 0.460 |
MOD_PIKK_1 | 341 | 347 | PF00454 | 0.449 |
MOD_PIKK_1 | 77 | 83 | PF00454 | 0.151 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.551 |
MOD_PKA_2 | 81 | 87 | PF00069 | 0.214 |
MOD_Plk_1 | 269 | 275 | PF00069 | 0.309 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.474 |
MOD_Plk_4 | 371 | 377 | PF00069 | 0.462 |
MOD_SUMO_for_1 | 396 | 399 | PF00179 | 0.413 |
MOD_SUMO_rev_2 | 186 | 195 | PF00179 | 0.258 |
TRG_DiLeu_BaEn_1 | 321 | 326 | PF01217 | 0.407 |
TRG_DiLeu_BaEn_1 | 365 | 370 | PF01217 | 0.442 |
TRG_DiLeu_BaEn_3 | 398 | 404 | PF01217 | 0.295 |
TRG_DiLeu_BaEn_4 | 365 | 371 | PF01217 | 0.444 |
TRG_DiLeu_BaLyEn_6 | 249 | 254 | PF01217 | 0.323 |
TRG_DiLeu_BaLyEn_6 | 336 | 341 | PF01217 | 0.465 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.258 |
TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 408 | 411 | PF00928 | 0.379 |
TRG_ER_diArg_1 | 134 | 136 | PF00400 | 0.151 |
TRG_ER_diArg_1 | 250 | 252 | PF00400 | 0.348 |
TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 326 | 329 | PF00400 | 0.451 |
TRG_NES_CRM1_1 | 365 | 377 | PF08389 | 0.325 |
TRG_NLS_MonoExtC_3 | 1 | 6 | PF00514 | 0.656 |
TRG_Pf-PMV_PEXEL_1 | 15 | 19 | PF00026 | 0.479 |
TRG_Pf-PMV_PEXEL_1 | 251 | 255 | PF00026 | 0.333 |
TRG_Pf-PMV_PEXEL_1 | 43 | 47 | PF00026 | 0.442 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0M7 | Leptomonas seymouri | 82% | 100% |
A0A1X0NVQ9 | Trypanosomatidae | 55% | 99% |
A0A3S5H7I5 | Leishmania donovani | 94% | 100% |
A0A422NKR1 | Trypanosoma rangeli | 54% | 99% |
A2SPC3 | Methanocorpusculum labreanum (strain ATCC 43576 / DSM 4855 / Z) | 24% | 100% |
A4HG46 | Leishmania braziliensis | 89% | 100% |
A4I376 | Leishmania infantum | 94% | 100% |
D0A7Q2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 99% |
O27463 | Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) | 23% | 100% |
O57864 | Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) | 23% | 100% |
O82387 | Arabidopsis thaliana | 24% | 80% |
P81413 | Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) | 24% | 100% |
Q4JAS8 | Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) | 23% | 100% |
Q4Q8R7 | Leishmania major | 94% | 100% |
Q5N897 | Oryza sativa subsp. japonica | 23% | 84% |
Q8W032 | Arabidopsis thaliana | 25% | 85% |
Q975X3 | Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) | 25% | 100% |
Q980N4 | Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) | 25% | 100% |
Q9V2F2 | Pyrococcus abyssi (strain GE5 / Orsay) | 25% | 100% |
V5D7Z4 | Trypanosoma cruzi | 56% | 96% |